Bicara Therapeutics Inc (BCAX)

01:10 AM

Bicara Therapeutics (BCAX): Reassessing Valuation After Breakthrough Therapy Designation and Strong Phase 1b Data - Yahoo Finance

01:10 AM

05:03 AM

Will Bicara Therapeutics Inc. stock sustain high P E ratios2025 Biggest Moves & Verified Entry Point Detection - Newser

05:03 AM

Dec 03, 2025

Skandinaviska Enskilda Banken AB publ Acquires 61,201 Shares of Bicara Therapeutics Inc. $BCAX - MarketBeat

Dec 03, 2025

Dec 02, 2025

Bicara Therapeutics (BCAX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Dec 02, 2025

Does Bicara Therapeutics Inc (BCAX) offer a good opportunity for investors? - Setenews

Dec 02, 2025

Dec 02, 2025

Positive Outlook for Bicara Therapeutics: Promising Phase 1b Results and Safety Profile Support Buy Rating - TipRanks

Dec 02, 2025

Dec 01, 2025

Bicara’s ficerafusp alfa shows consistent response rates at lower dose By Investing.com - Investing.com Nigeria

Dec 01, 2025

Dec 01, 2025

Bicara Therapeutics (BCTX) Releases Promising Early Data from Ca - GuruFocus

Dec 01, 2025

Dec 01, 2025

Bicara’s ficerafusp alfa shows consistent response rates at lower dose - Investing.com

Dec 01, 2025

Dec 01, 2025

Bicara Therapeutics Announces Publication of an Abstract - GlobeNewswire

Dec 01, 2025

Nov 30, 2025

Buy Rating for Bicara Therapeutics Driven by Promising Efficacy and Safety of FICERA in ESMO Asia Abstract - TipRanks

Nov 30, 2025

Nov 29, 2025

Bicara Therapeutics (NASDAQ:BCAX) Shares Down 3.3%Time to Sell? - MarketBeat

Nov 29, 2025

Nov 28, 2025

Wells Fargo Initiates Coverage of Bicara Therapeutics (BCAX) with Underweight Recommendation - MSN

Nov 28, 2025

Nov 27, 2025

What Analyst Ratings Reveal About Venus Pipes and Tubes Limiteds Future ValueShort-Term Trading Alerts & Turn Bull Runs into Life-Changing Wealth - earlytimes.in

Nov 27, 2025

Nov 27, 2025

What’s Bicara Therapeutics Inc (BCAX)’s Price to Earnings Ratio? - fostersleader.com

Nov 27, 2025

Nov 26, 2025

[424B5] Bicara Therapeutics Inc. Prospectus Supplement (Debt Securities) - Stock Titan

Nov 26, 2025

Nov 26, 2025

Hyep Ivan, Bicara Therapeutics CFO, sells $341k in BCAX stock - Investing.com Nigeria

Nov 26, 2025

Nov 26, 2025

Bicara Therapeutics (NASDAQ:BCAX) CFO Ivan Hyep Sells 605 Shares - MarketBeat

Nov 26, 2025

Nov 25, 2025

Hyep Ivan, Bicara Therapeutics CFO, sells $341k in BCAX stock By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 25, 2025

Bicara Therapeutics president Cohlhepp sells $225k in shares By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 25, 2025

[Form 4] Bicara Therapeutics Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025

Nov 25, 2025

Bicara Therapeutics president Cohlhepp sells $225k in shares - Investing.com

Nov 25, 2025

Nov 25, 2025

Bicara Therapeutics Executives Engage in Stock Sales - TradingView

Nov 25, 2025

Nov 25, 2025

Pres Cohlhepp Sells 12,500 ($225.6K) Of Bicara Therapeutics Inc [BCAX] - TradingView

Nov 25, 2025

Nov 25, 2025

Officer Raben Sells 11,000 ($205.1K) Of Bicara Therapeutics Inc [BCAX] - TradingView

Nov 25, 2025

Nov 25, 2025

Bicara Therapeutics: Intriguing Opportunity Given Rival Merus' $8B Buyout (NASDAQ:BCAX) - Seeking Alpha

Nov 25, 2025

Nov 25, 2025

Ready to Jump After Recent Trade: Bicara Therapeutics Inc (BCAX) - Setenews

Nov 25, 2025

Nov 21, 2025

CFO Hyep Files To Sell 605 Of Bicara Therapeutics Inc [BCAX] - TradingView

Nov 21, 2025

Nov 21, 2025

How Bicara Therapeutics Inc. stock reacts to job market data2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com

Nov 21, 2025

Nov 20, 2025

Is Bicara Therapeutics Inc. stock safe for conservative investors - newser.com

Nov 20, 2025

Nov 19, 2025

Why Bicara Therapeutics Inc. stock appeals to analysts2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What risks investors should watch in Bicara Therapeutics Inc. stock2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Should I hold or sell Bicara Therapeutics Inc. stock in 2025Insider Buying & Reliable Momentum Entry Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What dividend safety score for Bicara Therapeutics Inc. stockWall Street Watch & Long-Term Capital Growth Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives $29.67 Average Price Target from Analysts - Defense World

Nov 19, 2025

Nov 18, 2025

Analyzing Bicara Therapeutics Inc. with risk reward ratio chartsTrade Volume Report & High Conviction Buy Zone Picks - newser.com

Nov 18, 2025

Nov 18, 2025

Taking the lead: Bicara Therapeutics Inc (BCAX) - Setenews

Nov 18, 2025

Nov 18, 2025

Bicara Therapeutics (NASDAQ:BCAX) versus Senti Biosciences (NASDAQ:SNTI) Head to Head Analysis - Defense World

Nov 18, 2025

Nov 17, 2025

Bicara Therapeutics Inc. (NASDAQ:BCAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 17, 2025

Nov 16, 2025

How currency fluctuations impact Bicara Therapeutics Inc. stock2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

Nov 16, 2025